Skip to main content
NMTC
NASDAQ Industrial Applications And Services

Stockholders Approve Reverse Stock Split and Significant Equity Incentive Plan Expansion

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$0.795
Mkt Cap
$40.301M
52W Low
$0.395
52W High
$1.16
52W Position info
101% above low
Off High info
31% below high
Rel. Volume info
0.4× avg
Market data snapshot near publication time

NMTC has more than doubled off its 52-week low of $0.395.

Summary

Stockholders approved a reverse stock split (1-for-2 to 1-for-15) to address Nasdaq listing requirements and expanded the equity incentive plan, authorizing 1.5 million new shares plus annual 5% increases.


Key Events · Corporate Governance and Compliance · NMTC

  • Reverse Stock Split Approved

    Stockholders approved an amendment to the Certificate of Incorporation to effect a reverse stock split at a ratio between 1-for-2 and 1-for-15, to be determined by the Board of Directors. This move is typically aimed at increasing the per-share price to meet exchange listing requirements, following previous disclosures of Nasdaq delisting risk.

  • Equity Incentive Plan Expanded

    An amendment to the 2025 Equity Incentive Plan was approved, increasing the aggregate number of shares available for issuance by 1,500,000. The plan also includes an automatic annual increase of 5% of fully diluted shares each January 1st from 2027 to 2031, representing significant potential future dilution.

  • Directors Elected and Auditor Ratified

    Stockholders elected two Class III directors to serve three-year terms and ratified the appointment of Baker Tilly US, LLP as the independent registered public accounting firm for fiscal year 2026.


Analysis · NMTC · Industrial Applications And Services

Stockholders have approved a reverse stock split, a critical measure often undertaken by companies facing low stock prices to meet exchange listing requirements. This action directly addresses the Nasdaq delisting risk previously disclosed in the company's financial baseline. While necessary for continued listing, it signals underlying financial distress. Additionally, the approval of an amendment to the 2025 Equity Incentive Plan introduces substantial potential future dilution, with an immediate increase of 1.5 million shares and automatic 5% annual increases for five years. This further potential dilution, combined with the reverse split, indicates a challenging financial outlook for the company.

At the time of this filing, NMTC was trading at $0.80 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $40.3M. The 52-week trading range was $0.40 to $1.16. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

NMTC - Latest Insights

NMTC
Jun 12, 2026, 4:45 PM EDT
Filing Type: 424B5
Importance Score:
8
Price at Filing: $3.24
Real-time Price: $1.93 info
Change: -$1.31 (-40%) info
Market Cap: $16.536M info
NMTC
Jun 12, 2026, 4:45 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $3.24
Real-time Price: $1.93 info
Change: -$1.31 (-40%) info
Market Cap: $16.536M info
NMTC
Jun 12, 2026, 4:32 PM EDT
Filing Type: 10-Q/A
Importance Score:
9
Price at Filing: $3.24
Real-time Price: $1.93 info
Change: -$1.31 (-40%) info
Market Cap: $16.536M info
NMTC
May 22, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $3.72
Real-time Price: $1.93 info
Change: -$1.79 (-48%) info
Market Cap: $16.536M info
NMTC
May 12, 2026, 8:15 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $4.10
Real-time Price: $1.93 info
Change: -$2.17 (-53%) info
Market Cap: $16.536M info